Business Context and Reporting Period
Prestige Brands Holdings, Inc. (Registrant) filed this Form 8-K on September 21, 2006, to report the entry into a material definitive agreement. The filing details the acquisition of Wartner USA B.V. ("Wartner") by Medtech Products Inc., a wholly-owned subsidiary of the Registrant.
Key Financial Metrics
This filing reports on a specific transaction rather than periodic financial performance. Consequently, standard metrics such as revenue, profit, cash flow, margins, and debt levels are not provided in this document.
- Aggregate Purchase Price: $31,500,000 (subject to adjustments).
- Cash Paid at Closing: $31,050,684.
- Estimated Present Value of Earnouts: Approximately $5,000,000.
- Earnout Period: Through December 31, 2011.
Material Changes
The primary material change is the expansion of the Registrant's portfolio through the acquisition of Wartner. The transaction was executed via a Stock Sale and Purchase Agreement dated September 21, 2006, involving Lil' Drug Store Products, Inc. ("LDS") and certain LDS shareholders. The agreement includes customary representations, warranties, and indemnification provisions.
Outlook, Risks, and Contingencies
The filing incorporates a press release (Exhibit 99.1) regarding the acquisition. The transaction structure includes contingent earnout payments extending through 2011, indicating that future financial obligations depend on Wartner's performance. The filing does not provide specific management commentary on future guidance or detailed risk factors beyond the standard contractual terms of the acquisition.
Investor Verification Checklist
- Verify the specific performance metrics triggering the earnout payments through 2011.
- Review the full Stock Sale and Purchase Agreement for details on purchase price adjustments.
- Examine the press release (Exhibit 99.1) for strategic rationale and product details regarding Wartner.
- Confirm the impact of the $31 million cash outflow on the company's liquidity in subsequent quarterly reports.